Mostrar el registro sencillo del ítem

dc.contributor.author
Chan, Pamela Y.  
dc.contributor.author
Carrera Silva, Eugenio Antonio  
dc.contributor.author
De Kouchkovsky, Dimitri  
dc.contributor.author
Joannas, Leonel D.  
dc.contributor.author
Hao, Liming  
dc.contributor.author
Hu, Donglei  
dc.contributor.author
Huntsman, Scott  
dc.contributor.author
Eng, Celeste  
dc.contributor.author
Licona Limón, Paula  
dc.contributor.author
Weinstein, Jason S.  
dc.contributor.author
De Broski, Herbert R.  
dc.contributor.author
Craft , Joseph E.  
dc.contributor.author
Flavell, Richard A.  
dc.contributor.author
Repetto, Silvia  
dc.contributor.author
Correale, Jorge  
dc.contributor.author
Burchard, Esteban G.  
dc.contributor.author
Torgerson, Dora G.  
dc.contributor.author
Ghosh, Sourav  
dc.contributor.author
Rothlin, Carla V.  
dc.date.available
2018-05-16T02:21:51Z  
dc.date.issued
2016-04  
dc.identifier.citation
Chan, Pamela Y.; Carrera Silva, Eugenio Antonio; De Kouchkovsky, Dimitri; Joannas, Leonel D.; Hao, Liming; et al.; The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity; American Association for the Advancement of Science; Science; 352; 6281; 4-2016; 99-103  
dc.identifier.issn
0036-8075  
dc.identifier.uri
http://hdl.handle.net/11336/45316  
dc.description.abstract
Host responses against metazoan parasites or an array of environmental substances elicit type 2 immunity. Despite its protective function, type 2 immunity also drives allergic diseases. The mechanisms that regulate the magnitude of the type 2 response remain largely unknown. Here, we show that genetic ablation of a receptor tyrosine kinase encoded byTyro3in mice or the functional neutralization of its ortholog in human dendritic cells resulted in enhanced type 2 immunity. Furthermore, the TYRO3 agonist PROS1 was induced in T cells by the quintessential type 2 cytokine, interleukin-4. T cell-specificPros1knockouts phenocopied the loss ofTyro3 Thus, a PROS1-mediated feedback from adaptive immunity engages a rheostat, TYRO3, on innate immune cells to limit the intensity of type 2 responses.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
American Association for the Advancement of Science  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Tam Family  
dc.subject
Tyro 3  
dc.subject
Type 2 Immunity  
dc.subject
Blood Proteins  
dc.subject
Interleukin 4  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-05-03T13:59:42Z  
dc.identifier.eissn
1095-9203  
dc.journal.volume
352  
dc.journal.number
6281  
dc.journal.pagination
99-103  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Nueva York  
dc.description.fil
Fil: Chan, Pamela Y.. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Carrera Silva, Eugenio Antonio. University of Yale. School of Medicine; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: De Kouchkovsky, Dimitri. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Joannas, Leonel D.. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Hao, Liming. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Hu, Donglei. University of California; Estados Unidos  
dc.description.fil
Fil: Huntsman, Scott. University of California; Estados Unidos  
dc.description.fil
Fil: Eng, Celeste. University of California; Estados Unidos  
dc.description.fil
Fil: Licona Limón, Paula. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Weinstein, Jason S.. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: De Broski, Herbert R.. University of California; Estados Unidos  
dc.description.fil
Fil: Craft , Joseph E.. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Flavell, Richard A.. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Repetto, Silvia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones en Microbiología y Parasitología Médica. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones en Microbiología y Parasitología Médica; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Correale, Jorge. Fundación para la Lucha Contra las Enfermedades Neurológicas de la Infancia. Instituto de Investigaciones Neurológicas ; Argentina  
dc.description.fil
Fil: Burchard, Esteban G.. University of California; Estados Unidos  
dc.description.fil
Fil: Torgerson, Dora G.. University of California; Estados Unidos  
dc.description.fil
Fil: Ghosh, Sourav. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Rothlin, Carla V.. University of Yale. School of Medicine; Estados Unidos  
dc.journal.title
Science  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://science.sciencemag.org/content/352/6281/99.long  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1126/science.aaf1358  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935984/